Literature DB >> 15810962

WT-1 in ovarian and endometrioid serous carcinoma: a meta-analysis.

M K Heatley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15810962     DOI： 10.1111/j.1365-2559.2004.02005.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

1.  Coordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomas.

Authors:  Oluwole Fadare; Samuel James; Mohamed M Desouki; Dineo Khabele
Journal:  Ann Diagn Pathol       Date:  2013-05-21       Impact factor: 2.090

2.  Wilms' Tumour gene 1 (WT1) as an immunotherapeutic target.

Authors:  A Coosemans
Journal:  Facts Views Vis Obgyn       Date:  2011

3.  Evaluation of the incidence and clinical significance of WT-1 expression in uterine serous carcinoma.

Authors:  Jennifer McEachron; Agha Wajdan Baqir; Nancy Zhou; Absia Jabbar; Raavi Gupta; Daniel Levitan; Yi-Chun Lee
Journal:  Gynecol Oncol Rep       Date:  2021-12-27

Review 4.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.